18f-dopamne    (DrugBank: -)

2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
6パーキンソン病1
17多系統萎縮症1

6. パーキンソン病 [臨床試験数:2,123,薬物数:2,046(DrugBank:324),標的遺伝子数:183,標的パスウェイ数:198
Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,123 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03648905
(ClinicalTrials.gov)
September 6, 201824/8/2018Clinical Laboratory Evaluation of Chronic Autonomic FailureClinical Laboratory Evaluation of Chronic Autonomic FailureParkinson's Disease;Multiple System Atrophy;Autonomic FailureDrug: 18F-Dopa;Drug: 11C-methylreboxetine;Drug: 13N-Ammonia;Drug: 18F-Dopamne;Drug: Desipramine (DMI)National Institute of Neurological Disorders and Stroke (NINDS)NULLRecruiting18 YearsN/AAll140Phase 1United States

17. 多系統萎縮症 [臨床試験数:107,薬物数:153(DrugBank:48),標的遺伝子数:59,標的パスウェイ数:104
Searched query = "Multiple system atrophy", "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 107 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03648905
(ClinicalTrials.gov)
September 6, 201824/8/2018Clinical Laboratory Evaluation of Chronic Autonomic FailureClinical Laboratory Evaluation of Chronic Autonomic FailureParkinson's Disease;Multiple System Atrophy;Autonomic FailureDrug: 18F-Dopa;Drug: 11C-methylreboxetine;Drug: 13N-Ammonia;Drug: 18F-Dopamne;Drug: Desipramine (DMI)National Institute of Neurological Disorders and Stroke (NINDS)NULLRecruiting18 YearsN/AAll140Phase 1United States